Industry Briefs: October 15, 2012

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Oct 18, 2012
By PharmTech Editors

Company News

Paladin Labs has entered into a licensing agreement with QRxPharma whereby Paladin received the exclusive rights to market and sell Moxduo, for treating acute pain, in Canada. Read More

Theravance and Merck & Co. have agreed to discover, develop, and commercialize small-molecule therapeutics directed toward a target being investigated for treating of hypertension and heart failure. Read More

People News

Amgen has appointed Cynthia Patton as senior vice-president and chief compliance officer. Read More

Sirona Biochem has named Neil Belenkie as CEO. Read More

Unilife has expanded its commercial development team with the appointment of four senior executives. Read More